Sébastien Marque

735 total citations
24 papers, 498 citations indexed

About

Sébastien Marque is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Sébastien Marque has authored 24 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Pathology and Forensic Medicine and 4 papers in Epidemiology. Recurrent topics in Sébastien Marque's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). Sébastien Marque is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). Sébastien Marque collaborates with scholars based in France, United States and Austria. Sébastien Marque's co-authors include M. Munteanu, Jean‐François Dartigues, Marion Houot, Yen Ngo, Daniel Commenges, Thierry Poynard, Hélène Jacqmin‐Gadda, Salim Si‐Mohamed, Vincent Cottin and Françoise Thivolet-Béjui and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Respiratory Journal.

In The Last Decade

Sébastien Marque

21 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sébastien Marque France 12 185 144 120 67 59 24 498
Han Saem Choi South Korea 15 153 0.8× 116 0.8× 53 0.4× 66 1.0× 203 3.4× 45 676
Satoshi Takasaki Japan 13 86 0.5× 103 0.7× 57 0.5× 38 0.6× 96 1.6× 42 659
Jacek Borawski Poland 13 91 0.5× 55 0.4× 62 0.5× 27 0.4× 97 1.6× 48 656
Mirian Starmans‐Kool Netherlands 8 121 0.7× 32 0.2× 47 0.4× 41 0.6× 89 1.5× 11 854
P. Knudsen Denmark 7 167 0.9× 105 0.7× 31 0.3× 84 1.3× 87 1.5× 9 763
Murat Devecí Türkiye 11 89 0.5× 63 0.4× 36 0.3× 32 0.5× 87 1.5× 45 530
Jung‐Hyun Lee South Korea 11 57 0.3× 295 2.0× 44 0.4× 80 1.2× 56 0.9× 21 571
Valeria Falqui Italy 15 135 0.7× 89 0.6× 35 0.3× 118 1.8× 84 1.4× 29 771
R de Marco Italy 8 75 0.4× 237 1.6× 99 0.8× 56 0.8× 105 1.8× 9 643

Countries citing papers authored by Sébastien Marque

Since Specialization
Citations

This map shows the geographic impact of Sébastien Marque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Marque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Marque more than expected).

Fields of papers citing papers by Sébastien Marque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Marque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Marque. The network helps show where Sébastien Marque may publish in the future.

Co-authorship network of co-authors of Sébastien Marque

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Marque. A scholar is included among the top collaborators of Sébastien Marque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Marque. Sébastien Marque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cottin, Vincent, Sophie Larrieu, Loïc Boussel, et al.. (2021). Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France. Frontiers in Medicine. 8. 699532–699532. 9 indexed citations
3.
Nasser, Mouhamad, Sophie Larrieu, Loïc Boussel, et al.. (2021). Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study). Respiratory Research. 22(1). 162–162. 40 indexed citations
4.
Nasser, Mouhamad, Sophie Larrieu, Salim Si‐Mohamed, et al.. (2020). Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study). European Respiratory Journal. 57(2). 2002718–2002718. 128 indexed citations
8.
Sennoune, Souad R., et al.. (2017). Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial. Cellular and Molecular Biology. 63(9). 122–131. 6 indexed citations
9.
Caplain, Sophie, Sophie Blancho, Sébastien Marque, Michèle Montreuil, & Nozar Aghakhani. (2017). Early Detection of Poor Outcome after Mild Traumatic Brain Injury: Predictive Factors Using a Multidimensional Approach a Pilot Study. Frontiers in Neurology. 8. 666–666. 23 indexed citations
10.
Chassaing, V., et al.. (2017). Tibial tubercle torsion, a new factor of patellar instability. Orthopaedics & Traumatology Surgery & Research. 103(8). 1173–1178. 21 indexed citations
11.
Berdaï, Driss, Karine Szwarcensztein, Anne d’Andon, et al.. (2017). Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases. Therapies. 73(1). 13–24. 5 indexed citations
12.
Berdaï, Driss, Karine Szwarcensztein, Anne d’Andon, et al.. (2017). Demandes d’études post-inscription (EPI), suivi des patients en vie réelle : évolution de la place des bases de données. Therapies. 73(1). 1–12. 2 indexed citations
13.
Guérin, Patrice, et al.. (2016). MitraClip therapy in mitral regurgitation: a Markov model for the cost-effectiveness of a new therapeutic option. Journal of Medical Economics. 19(7). 696–701. 15 indexed citations
14.
Houot, Marion, Yen Ngo, M. Munteanu, Sébastien Marque, & Thierry Poynard. (2015). Systematic review with meta‐analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Alimentary Pharmacology & Therapeutics. 43(1). 16–29. 73 indexed citations
15.
Marque, Sébastien, et al.. (2014). Prise en charge des crises épileptiques chez l'enfant : une analyse d'impact budgétaire. Vol. 31(7). 445–456.
16.
Micheaux, Pierre Lafaye de, Benoît Liquet, Sébastien Marque, & Jérémie Riou. (2014). Power and Sample Size Determination in Clinical Trials with Multiple Primary Continuous Correlated Endpoints. Journal of Biopharmaceutical Statistics. 24(2). 378–397. 18 indexed citations
17.
Baud, Frédéric J., et al.. (2013). Intoxications graves en réanimation : étude des substances annoncées en 2011. Annales Pharmaceutiques Françaises. 71(3). 174–185.
18.
Pizarro, Fernando, José Boccio, María Jimena Salgueiro, et al.. (2012). Bioavailability of Stabilised Ferrous Gluconate with Glycine in Fresh Cheese Matrix: a Novel Iron Compound for Food Fortification. Biological Trace Element Research. 151(3). 441–445. 5 indexed citations
19.
Jacquemier, Jocelyne, Frédérique Penault‐Llorca, Héla Mnif, et al.. (2006). Identification of a basal-like subtype and comparative effect of epirubicin-based chemotherapy and sequential epirubicin followed by docetaxel chemotherapy in the PACS 01 breast cancer trial: 33 markers studied on tissue-microarrays (TMA). Journal of Clinical Oncology. 24(18_suppl). 509–509. 21 indexed citations
20.
Marque, Sébastien, Hélène Jacqmin‐Gadda, Jean‐François Dartigues, & Daniel Commenges. (2003). Cardiovascular mortality and calcium and magnesium in drinking water: An ecological study in elderly people. European Journal of Epidemiology. 18(4). 305–309. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026